Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy. - Giovannoni F; Strathdee CA; Faust Akl C; Andersen BM; Li Z; Lee HG; Torti MF; Rone JM; Duart-Abadia P; Molgora M; Kong L; Floyd M; et al. (Nature cancer, 2025)